CUSIP 04280A100COMARWRQ4 2025
31 filings · latest Jan 21, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 21.32M | $1.42B |
| 2 | Vanguard Group Inc | 15.29M | $1.02B |
| 3 | Avoro Capital Advisors LLC | 10.63M | $705.39M |
| 4 | Fmr LLC | 6.52M | $432.89M |
| 5 | State Street Corp | 6.40M | $425.15M |
| 6 | Geode Capital Management, LLC | 3.26M | $216.80M |
| 7 | Slate Path Capital LP | 2.52M | $167.54M |
| 8 | Baker Bros. Advisors LP | 2.18M | $144.44M |
| 9 | Arrowstreet Capital, Limited Partnership |
| 4 | Aug 11, 2025 | State Street Corporation | 13G | 4.6% | 6.37M | SEC |
| 5 | Jul 29, 2025 | The Vanguard Group | 13G/A | 11.2% | 15.53M | SEC |
| 6 | May 13, 2025 | State Street Corporation | 13G | 5.1% | 7.00M | SEC |
| 7 | Apr 23, 2025 | Blackrock, Inc. | 13G/A | 13.8% | 19.01M | SEC |
| 8 | Feb 14, 2025 | Sarepta Therapeutics, Inc. | 13D | 9.5% | — | SEC |
| 9 | Feb 14, 2025 | Avoro Capital Advisors LLC | 13G/A | 9.6% | 12.03M | SEC |
| 10 | Feb 5, 2025 | State Street Corporation | 13G | 4.8% | 6.02M | SEC |
See the full Schedule 13D/13G history for Arrowhead Pharmaceuticals In.
Unlock full history| 2.09M |
| $138.62M |
| 10 | Fred Alger Management, LLC | 1.83M | $121.69M |